A Phase I Study of PepGNP-ChikV in Healthy Volunteers
A Phase I Study of PepGNP-ChikV in Healthy Volunteers
Not yet recruiting · NCT07394426 · Registry updated 2026-04-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase I Study of PepGNP-ChikV in Healthy Volunteers | Alphavirus infectious disease, Disease Attributes, Infections, Mosquito-Borne Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, RNA Virus Infections, Togaviridae infectious disease, arbovirus infection, chikungunya, infectious disease, vector-borne disease, viral infectious disease | Not yet recruiting | Early phase 1 | 2026-04-29 | NCT07394426 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Gylden Pharma Ltd | 2 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||